You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 9, September 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Announcement
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

50 Years Ago in the Archives

Arch Ophthalmol. 2007;125(9):1281.

I believe that the use of nonspecific protein therapy has been largely supplanted by the use of steroids. I am far from being in sympathy with the promiscuous use of steroid therapy, especially in granulomatous uveitis. This I have endeavored to emphasize in my recent book. Nonspecific therapy with foreign proteins still has a place in certain forms of uveitis, but with the introduction of specific antibacterial therapy, and nonspecific steroid treatment, I believe its present use is somewhat limited.
—Alan C. Woods, Johns Hopkins Hospital, Baltimore, Maryland

Reference: Nielsen RH, Kirby TJ. The modern treatment of uveitis. Arch Ophthalmol. 1957;58(1):103.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.